针对毒素向IgG1抗体的pH依赖抗原结合性能的工程,使用轻链混
Tulika Tulika1, Fulgencio Ruso-Julve2, Shirin Ahmadi1
1Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Structure (London, England : 1993)
|August 15, 2024
概括
具有pH依赖结合的工程免疫球蛋白G (IgG) 抗体提供了更好的抗原中和和更低的剂量要求. 这项研究展示了一种使用光链混合和菌体显示来创造这些先进抗体的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 蛋白质工程是指蛋白质工程.
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有pH依赖抗原结合的免疫球蛋白G (IgG) 抗体 (酸切换抗体) 可以在酸性内体中释放抗原以进行降解.
- 这种依赖pH的释放允许IgG被新生儿Fc受体 (FcRn) 挽救,使多个抗原随着时间的推移和潜在的较低治疗剂量的中和成为可能.
- 设计这种pH响应性抗体是复杂的,需要仔细考虑抗原结合,FcRn相互作用和细胞处理.
研究的目的:
- 调查光链混合与菌体显示技术相结合的使用,以发现具有增强pH依赖抗原结合性质的IgG1抗体.
- 分析选择的IgG1与其向抗原 (myotoxin II和α-cobratoxin) 和人类新生儿Fc受体 (FcRn) 的结合相互作用.
- 阐明如何工程化pH依赖结合和FcRn相互作用影响抗体-抗原复合物的细胞处理和循环.
主要方法:
- 应用轻链混合和菌体显示技术来识别具有增加pH依赖抗原结合的IgG1抗体.
- 在不同的pH条件下,选择的抗体对向蛇毒毒素和人类FcRn的结合动力学和亲和力的表征.
- 评估细胞抗体-抗原处理特性,包括吸收,释放和回收,受pH依赖的结合和FcRn相互作用的影响.
主要成果:
- 通过使用描述的方法成功发现了IgG1抗体,其具有增强的pH依赖的抗原结合特性.
- 鉴定工程IgG1对它们的抗原和FcRn的独特结合配置,与它们的pH依赖表型相关.
- 展示Fc工程如何改善FcRn结合影响细胞抗体-抗原循环动态.
结论:
- 轻链混合和菌体显示是设计IgG1抗体的有效工具,具有量身定制的pH依赖的抗原结合特性.
- 该研究强调了pH依赖抗原结合,FcRn相互作用和由此产生的细胞抗体-抗原代谢之间的复杂关系.
- 设计pH依赖的IgG1抗体为开发具有提高疗效和降低剂量要求的治疗方法提供了一个有希望的战略,尽管必须解决设计和细胞处理的复杂性.
关键词:
抗体回收回收的方法在FcRnnn中.这里是HERA.用酸切换的抗体.以人体内皮细胞为基础的回收试验.轻链混动的混合方式肌毒素II 的使用.具有依赖pH值的抗原结合特性.体显示技术的体显示技术蛇毒是一种蛇毒.α-cobratoxin 的使用情况.更多相关视频
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
7.7K
12:28Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
Published on: October 15, 2016
11.5K
相关概念视频
01:10Antibody Structure
59.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.6K
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:31Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K
01:25Antibody Structure and Classes
859
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
859